Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives as selective inhibitors of EGFR threonine790 to methionine790 (T790M) mutants

Tianfeng Xu, Lianwen Zhang, Shilin Xu, Chao Yie Yang, Jinfeng Luo, Fang Ding, Xiaoyun Lu, Yingxue Liu, Zhengchao Tu, Shiliang Li, Duanqing Pei, Qian Cai, Honglin Li, Xiaomei Ren, Shaomeng Wang, Ke Ding

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Catching the mutants: Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives (see example) were identified as specific inhibitors of EGFRT790M mutants. The compounds bound with T790M or L858R/T790M mutants with significantly lower Kd values than that with EGFRWT. They also selectively inhibited EGFR signal transduction and proliferation of NSCLC cells harboring EGFRL858R/T790M mutation, but were significantly less potent to cells with EGFRWT.

Original languageEnglish
Pages (from-to)8387-8390
Number of pages4
JournalAngewandte Chemie - International Edition
Volume52
Issue number32
DOIs
StatePublished - 5 Aug 2013
Externally publishedYes

Keywords

  • T790M mutants
  • drug design
  • inhibitors
  • selectivity

Fingerprint

Dive into the research topics of 'Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives as selective inhibitors of EGFR threonine790 to methionine790 (T790M) mutants'. Together they form a unique fingerprint.

Cite this